Mito, Muscle & GLP‑1 Mastery is a clinically focused course that shows you how to protect muscle, optimize mitochondria, and use GLP‑1s without sacrificing metabolic healthor longevity.
Why This Workshop Now
GLP‑1 and dual agonists are transforming obesity care, but rapid weight loss can quietly erode lean mass, VO2, and long‑term resilience if not managed with a muscle‑centric strategy.
Mitochondrial function, metabolic flexibility, and body composition are emerging as core longevity levers, often predicting outcomes more powerfully than traditional markers alone.
What You Will Learn
Connect mitochondrial health, metabolic flexibility, and body composition to healthspan and biological age using practical biomarkers (VO2, HRV, lactate, phase angle, visceral fat).
Implement evidence‑based protocols that pair GLP‑1 therapy with resistance training, protein optimization, and mitochondrial support to prevent sarcopenic obesity and VO2 decline.
Interpret BIA/DXA and related tools as “vital signs” for visceral fat, skeletal muscle quality, and sarcopenia risk, and build repeatable assessment workflows into your practice.
Design “metabolic resuscitation” visits and 6–12 month muscle‑centric programs that integrate GLP‑1s, VO2 and body composition testing, and mitochondrial therapeutics.
Who Should Register
Clinicians actively prescribing or considering GLP‑1s who want to ensure patients lose fat, not muscle: MD, DO, NP, PA, PharmD, DC, and allied professionals in metabolic, obesity, and longevity medicine.
Providers building or expanding programs around VO2 testing, body composition analysis, and muscle‑centric longevity who need step‑by‑step clinical and operational frameworks.1‑Day Workshop Agenda
Course Curriculum
James LaValle, RpH, CCN, MT | 0.25 hr
- Core mitochondrial biology in aging and cardiometabolic disease
- Translating VO2, HRV, lactate and functional capacity into clinical decision making
- How mitochondrial dysfunction show up in everyday cardiology and primary-care practice (hypertension, dyslipidemia, PFpEF, “normal” EF low reserve)
- Practical strategies to align mitochondrial support with cardiometabolic risk reduction and vascular health
- Impact of GLP-1/dual agonists on body composition, VO2, and metabolic flexibility
- Preventing sarcopenic obesity and fitness decline while leveraging GLP-1 benefits
- Interpreting BIA/DXA and related tools for visceral fat, skeletal muscle, and phase angle
- Building baseline and follow-up workflow for GLP-1 and longevity programs
Training to stimulate muscle growth
Cliff Edberg, RD, CPT | 1 hr
Kiran Krishnan, PhD | 0.5 hr
- 2–3 focused cases (e.g., rapid GLP 1 weight loss with lean mass loss; older adult with sarcopenic obesity; perimenopausal patient with visceral adiposity and fatigue).
- Walk through labs, body comp, VO₂ and design integrated protocols (meds, training, nutrition, mito/vascular support, follow up testing).
- Designing “metabolic resuscitation” days (VO2 + BIA + labs + visit)
- 6-12 month program structures, visit cadence, testing intervals, and communication strategies focused on energy, function, and biological age – not just scale weight.
Faculty Panel | 0.25 hr